Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Clinical trial NCT01312961 · COMPLETED
Trial details
- NCT number
- NCT01312961
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2012-10-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.